Everest Re Group Ltd (NYSE:RE) VP John P. Doucette sold 300 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $242.84, for a total value of $72,852.00. Following the completion of the sale, the vice president now directly owns 21,434 shares of the company’s stock, valued at approximately $5,205,032.56. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Everest Re Group Ltd (NYSE:RE) traded up $0.35 on Friday, reaching $239.75. The company had a trading volume of 17,879 shares, compared to its average volume of 394,530. Everest Re Group Ltd has a twelve month low of $208.81 and a twelve month high of $277.17. The company has a current ratio of 0.31, a quick ratio of 0.33 and a debt-to-equity ratio of 0.08. The company has a market cap of $9,798.19, a PE ratio of 27.11, a PEG ratio of 1.12 and a beta of 0.59.
Everest Re Group (NYSE:RE) last posted its quarterly earnings results on Monday, February 5th. The insurance provider reported $13.48 earnings per share for the quarter, beating analysts’ consensus estimates of $6.04 by $7.44. Everest Re Group had a return on equity of 4.51% and a net margin of 7.10%. The business had revenue of $1.87 billion for the quarter, compared to analysts’ expectations of $1.52 billion. During the same quarter in the prior year, the business earned $9.08 EPS. The firm’s revenue for the quarter was up 15.7% on a year-over-year basis. analysts predict that Everest Re Group Ltd will post 21.45 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 21st. Shareholders of record on Wednesday, March 7th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 2.17%. The ex-dividend date is Tuesday, March 6th. Everest Re Group’s payout ratio is 46.68%.
A number of research firms recently weighed in on RE. Zacks Investment Research upgraded Everest Re Group from a “hold” rating to a “strong-buy” rating and set a $253.00 price target on the stock in a research note on Friday, January 5th. Wells Fargo & Co restated a “market perform” rating and issued a $235.00 price target (down previously from $240.00) on shares of Everest Re Group in a research note on Tuesday, January 9th. Keefe, Bruyette & Woods upgraded Everest Re Group from an “underperform” rating to a “market perform” rating in a research note on Monday, November 27th. UBS Group increased their price target on Everest Re Group from $230.00 to $245.00 and gave the company a “neutral” rating in a research note on Monday, November 6th. Finally, TheStreet upgraded Everest Re Group from a “c+” rating to a “b-” rating in a research note on Monday, January 22nd. Eight equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $254.13.
Hedge funds have recently bought and sold shares of the business. Focused Wealth Management Inc bought a new position in Everest Re Group during the 4th quarter worth $111,000. Valeo Financial Advisors LLC bought a new position in Everest Re Group during the 3rd quarter worth $137,000. Cerebellum GP LLC bought a new position in Everest Re Group during the 4th quarter worth $133,000. Tower Research Capital LLC TRC bought a new position in Everest Re Group during the 4th quarter worth $144,000. Finally, Fuller & Thaler Asset Management Inc. increased its position in Everest Re Group by 87.5% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 750 shares of the insurance provider’s stock worth $166,000 after buying an additional 350 shares during the period. Hedge funds and other institutional investors own 92.14% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/23/john-p-doucette-sells-300-shares-of-everest-re-group-ltd-re-stock.html.
About Everest Re Group
Everest Re Group, Ltd., through its subsidiaries, is engaged in the underwriting of reinsurance and insurance in the United States, Bermuda and international markets. The Company operates in segments: U.S. Reinsurance, International, Bermuda and Insurance segment. The Company underwrites reinsurance both through brokers and directly with ceding companies.
Receive News & Ratings for Everest Re Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everest Re Group and related companies with MarketBeat.com's FREE daily email newsletter.